Background: Chlorpromazine (CPZ) is a phenothiazine tranquilizer used in humans and animals. Rapid determination of the drug in pharmaceutical preparations is often needed. The aim of the study was to further examine and ascertain asimple spectrophotometric method in comparison with a high performance liquid chromatographic (HPLC) method for the determination of CPZ concentrations in injectable pharmaceutical formulations used in man and animals. Methods: Concentrations of CPZ in injectable pharmaceutical formulations for human and veterinary uses were determined by a modified spectrophotometric method and by an HPLC method with appropriate standard calibration curves. The spectrophotometric method of CPZ determinationwas conducted by diluting 0.1 ml of the veterinary (5%) or 0.3 ml of human (0.5%) formulations to 200 ml of 0.1N sulfuric acid. Four ml of the diluted CPZ samples or the standard solutions were mixed with 2 ml of 50% sulfuric acid. Then an aliquot of 0.2 ml of 2% ferric nitrate was added to the mixture. After 15 minutes, the absorbance was measured at 530 nm against water and vehicle blanks using a spectrophotometer. The HPLC method applied in the present study consisted of reversed phase gradient chromatography with a C 18 column and the eluent was (A) 50 mmol NaH 2 PO 4 , pH 2.5 and (B) acetonitrile -50 mmol NaH 2 PO 4 , pH 2.5 (60:40 v/v), flow rate at 1 ml/min, with a gradient of 15-55% B in 10 min, to 100% B in 20 min, and 280-nm UV detection. From the calibration curves of CPZ standards, the following were calculated: Limit of detection limit (LOD) = 3.3 x SD/slope; Limit of quantitation (LOQ) = 10 x SD/slope, where SD is the standard deviation of response of CPZ concentrations of the calibration curves.Linear regression analysis and related coefficients of correlations were applied on the calibration curves. Results: The calibration curves of CPZ against water or vehicle blanks as determined by the spectrophotometric method or by the HPLC method were linear with strong correlations (r = and / or >0.99). Based on the calibration curves, limit of detection and limit of quantitation the spectrophotometric method were comparable to those of the HPLC one. The contents CPZ in human and veterinary injectable formulations as determined by the spectrophotometricmethod were in accordance (100.6% and 102%, respectively)to the concentrations claimed on the labels of the formulations.
Conclusion:The present results introduce a simple spectrophotometric method that could be used for routine measurement of CPZ concentrations in pharmaceutical formulations, with the added benefits of linearity, precision and cost effectiveness.